Professor Geist, in your opening comments you spoke of health and safety, and of the value of the existing statutes and case law. You also spoke of the danger, of course, of unintended consequences. So with all of this in mind, would you please tell me briefly what you think of Bill C-8? Will it have unintended consequences, specifically for the generics industry?
On November 6th, 2013. See this statement in context.